EuroBioForum 2nd Annual Conference is co-hosted by BioM
BioM is the central agency for management and developing biotechnology in Munich.
2nd Annual Conference
A collaborative approach
to Personalised Medicine
27-28 May 2013
Hilton Munich City, Munich, Germany
The EuroBioForum Annual Conference 2013 is a forum to exchange views on the state of affairs in policy development and deployment, and on the challenges with respect to policies, implementation strategies and required investments.
Personalised Medicine needs involvement of all stakeholders: how can we address the challenges to find solutions? The complexity of diseases and the biology of humans is calling for a different approach. But the question is whether the current focus of Personalised Medicine is the solution. What are current perspectives in policy making and funding of Personalised Medicine? How can the aforementioned issues be addressed? How to tackle the future challenges in Personalised Medicine?
This year the Conference will explore the potential areas for transnational and transregional collaboration. Leading experts will offer insight into current developments in their countries and regions. We expect contributions from Germany, Canada, Norway, Switzerland, Belgium and various European regions in Spain, France, Sweden, Italy and Austria.
Registration has been closed!
As of 17 May 2013, the online registration for EuroBioForum 2nd Annual Conference is closed. However you are still very welcome to participate and join us on 27 – 28 May 2013 in Munich. Please send an e-mail to Ellen de Waal, Comunications Director of EuroBioForum, so we can still incorporate your details in the conference materials.
Wouter Spek, Managing director of EuroBioForum, speaking about the 2nd Annual Conference.
Check our other videos on YouTube: www.youtube.com/eurobioforum
BioM is the central agency for management and developing biotechnology in Munich. The Munich Biotech Region is running a € 100M programme to implement the new strategy to the cluster: m4 – Personalised Medicine and Targeted therapies. The Munich Biotech Region prepares itself to become a “international excellence center” in Personalised Medicine with more than 40 R&D-cooperation projects from academia and industry and more than 100 partners within this national programme. www.bio-m.org
Around 60 participants from 14 countries attended the 1st Annual Conference on the role of national funders, bioclusters and regions in Personalised Medicine, held in Brussels on 18 April 2012.
To read more on EuroBioForum activities, please visit: www.eurobioforum.eu
Programme update: speakers and venue confirmed! 02 Apr. 2013